Kyle Kyburz

Title: Innovations by Inventor Kyle Kyburz

Introduction

Kyle Kyburz is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for the drug apremilast. With a total of 3 patents to his name, Kyburz continues to push the boundaries of innovation in drug formulation.

Latest Patents

One of his notable patents involves the formulation of apremilast, which includes an oral dosage form comprising a core tablet. This core tablet consists of a drug layer that includes apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion. Additionally, it features a swellable layer made of one or more swellable polymers, along with a coating layer that has at least one drug release orifice. This innovative oral dosage form allows for once-a-day dosing of apremilast, making it suitable for treating diseases or disorders that can be improved by inhibiting phosphodiesterase subtype IV (PDE4).

Career Highlights

Kyle Kyburz is currently employed at Amgen Inc., a leading biotechnology company. His work focuses on developing advanced drug formulations that enhance patient compliance and therapeutic efficacy. His expertise in pharmaceutical sciences has positioned him as a key player in the industry.

Collaborations

Throughout his career, Kyburz has collaborated with talented individuals such as Nathan Bennette and William Brett Caldwell. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Kyle Kyburz is a prominent inventor whose work in drug formulation has the potential to significantly impact patient care. His innovative approaches to oral dosage forms exemplify the importance of research and development in the pharmaceutical industry.